MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617060133 A) filed by Synapse Research Institute on May 12, 2026, for Molecules For Reversing Anti-Coagulant Activity Of Direct Oral Anticoagulants.
Inventors include De Laat, Henricus Bastiaan; and Roest, Mark.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention relates to binding molecules capable of reversing the anti-coagulant activity of direct oral anticoagulants in-vivo and in-vitro. The present invention, more particularly concerns binding molecules for reversing the factor Xa inhibition activity of a factor Xa inhibitor such as in a patient to whom a factor Xa inhibitor ...